Gapping up
In reaction to strong earnings/guidance:
- ATEN +5.9%, LEN +4.8%, STZ +4.6%, RPM +1.9%, COLL +1.5%
Other news:
- APLT +24% (topline results from the Pivotal Phase 2 portion of the ACTION-Galactosemia study of AT-007)
- PSNL +2.7% (launches NeXT Dx Test for genomic cancer profiling)
- NOC +1.1% (defense name trading higher following Iranian missile strke on US bases)
- LMT +1% (defense name trading higher following Iranian missile strke on US bases) .
Analyst comments:
- CIEN +3.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- AIR +2.8% (upgraded to Buy from Hold at SunTrust)
- SGMS +2% (upgraded to Buy from Hold at Stifel)
- HL +1.8% (upgraded to Neutral from Sector Underperform at CIBC)
- DHR +1.3% (initiated with an Overweight at Wells Fargo)
- BLFS +0.8% (initiated with an Overweight at Stephens)
- OXY +0.7% (upgraded to Buy from Neutral at Mizuho)